Description
PROLASTIN FOR FARGO PHARMACY
First action · last action
2024-09-09 · 2025-02-26
Transactions
2
First transaction's obligation
$19,873
Base + all options value (sum of deltas)
$19,304
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79722D0090
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-09-09+$19,873= $19,873
- Mod P000012025-02-26-$569= $19,304
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-09-09 | +$19,873 | $19,873 | PROLASTIN FOR FARGO PHARMACY |
| Mod P00001· FUNDING ONLY ACTION | 2025-02-26 | −$569 | $19,304 | PROLASTIN FOR FARGO PHARMACY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI D48FNWJCJ5H5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026F0037 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $364,000 | FY2026 |
| 36C26026F0019 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $111,000 | FY2026 |
| 36C26026F0015 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $120,000 | FY2026 |
| 36C26025F0153 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $97,176 | FY2025 |
| 36C26025F0037 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36C26325F0017 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $103,293 | FY2025 |
Other recipients under 6515 from NETWORK CONTRACT OFFICE 23 (36C263) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26326F0127 | NATUS MEDICAL INCORPORATED | NETWORK CONTRACT OFFICE 23 (36C263) | $80,267 | FY2026 |
| 36C26326P0713 | APEX INTEGRATED DISTRIBUTION INC. | NETWORK CONTRACT OFFICE 23 (36C263) | $36,834 | FY2026 |
| 36C26326P0725 | PROAIM AMERICAS, LLC. | NETWORK CONTRACT OFFICE 23 (36C263) | $27,716 | FY2026 |
| 36C26326P0724 | WHEELCHAIR DYNAMICS INC | NETWORK CONTRACT OFFICE 23 (36C263) | $24,412 | FY2026 |
| 36C26326F0124 | PHILIPS NORTH AMERICA LLC | NETWORK CONTRACT OFFICE 23 (36C263) | $779,096 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26324N0859_3600_36F79722D0090_3600 · retrieved 2026-09-26.